Discover & Read Articles Without Distractions

Find and explore trending articles from around the web in a clutter-free reading mode.

Sign up for a free account and get the following:
  • Save articles and sync them across your devices
  • Get a digest of the latest premium articles in your inbox twice a week, personalized to you (Coming soon).
  • Get access to our AI features
  • Articles Tagged with "Pharmaceuticals"

    Alberta signed deal to import medication from Turkey despite recommendations against it - The Globe and Mail

    theglobeandmail.com Politics Canada

    Alberta's government controversially imported children's medication from Turkey despite expert warnings about potential financial losses, leading to investigations and legal disputes.

    Sanidad aparca la reforma del copago farmacéutico y resucita las subastas de medicamentos

    elespanol.com Healthcare Spain

    Spain's Ministry of Health has unveiled a revised pharmaceutical law, postponing the pharmaceutical co-payment reform and introducing a new drug auction system to increase competition and lower costs.

    Health lobby spending surged at end of 2024

    axios.com Politics USA

    Increased lobbying spending by healthcare groups, including pharmaceutical companies, PBMs, and physician associations, preceded a crucial government funding deal in late 2024.

    Trump da el primer paso para imponer aranceles a los chips y los productos farmacéuticos | Internacional | EL PAÍS

    elpais.com Politics United States

    Donald Trump is initiating investigations into imposing tariffs on imported microprocessors and pharmaceuticals, citing national security concerns and aiming to boost domestic production.

    White House, Florida promote Canada drug imports while tariff threat looms - The Globe and Mail

    theglobeandmail.com Politics World

    The White House and Florida are promoting Canadian drug imports to lower costs, despite potential US tariffs on pharmaceuticals.

    Bristol Myers shares fall after a failed trial. This is our plan for the stock — for now

    cnbc.com Finance World

    Bristol Myers Squibb's stock falls after a failed schizophrenia drug trial, prompting a cautious approach from the CNBC Investing Club.

    Helvetia-Baloise-Fusion: Grätscht Zurich noch dazwischen?

    themarket.ch Finance Switzerland

    The proposed Helvetia-Baloise merger faces uncertainty, with Zurich Insurance potentially making a counter-offer, while other Swiss companies like Roche, Novartis, Galderma, and Schindler navigate market challenges.